Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0018133 (graft-versus-host disease)
 18,032 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Monoclonal antibodies have proved invaluable in identification and characterization of hemopoietic cell surface macromolecules. We have used a number of these monoclonal antibody probes for immunohistochemical analysis of interstitial cell populations in diseased human kidney tissues and in certain prototypic cutaneous cellular immune reactions. The studies demonstrate that the relative proportions of T-cell subpopulations present in graft rejection (OKT8+ exceeding OKT4+) differ from those observed in drug nephrotoxicity and end-stage kidney disease. In this regard rejection resembles graft versus host disease of skin but not delayed-type hypersensitivity. However, analysis of cell populations in interstitial infiltrates from various forms of chronic renal disease (glomerulonephritis, end-stage renal disease of varied etiologies) failed to demonstrate any unique or characteristic profile. These studies led to the recognition that certain monoclonal antibodies directed against B- and leukemic cell surface antigens also bind to normal renal cells and that nephron development in the human fetus is characterized by differential binding of these probes.
Uremia Invest
PMID:Analysis of renal cell populations using monoclonal antibodies. 640 Jan 52

Neurological complications whether due to the uremic state or its treatment, contribute largely to the morbidity and mortality in patients with renal failure. Despite continuous therapeutic advances, many neurological complications of uremia, like uremic encephalopathy, atherosclerosis, neuropathy and myopathy fail to fully respond to dialysis. Moreover, dialytic therapy or kidney transplantation may even induce neurological complications. Dialysis can directly or indirectly be associated with dialysis dementia, dysequilibrium syndrome, aggravation of atherosclerosis, cerebrovascular accidents due to ultrafiltration-related arterial hypotension, hypertensive encephalopathy, Wernicke's encephalopathy, hemorrhagic stroke, subdural hematoma, osmotic myelinolysis, opportunistic infections, intracranial hypertension and mononeuropathy. Renal transplantation itself can give rise to acute femoral neuropathy, rejection encephalopathy and neuropathy in graft versus host disease. The use of immunosuppressive drugs after renal transplantation can cause encephalopathy, movement disorders, opportunistic infections, neoplasms, myopathy and progression of atherosclerosis. We address the clinical, pathophysiological and therapeutical aspects of both central and peripheral nervous system complications in uremia.
 ...
PMID:Neurological complications in renal failure: a review. 1556 46